glp 1 drugs for cardiovascular health GLP-1 Receptor Agonists the Reduction of Atherosclerotic Risk in Patients With Type 2 Diabetes The GLP-1 Era: Why These

For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al

J Cosmet Dermatol

But their efficacy doesn't stop there

Karakasis et al

M V Ramana, Chief Executive Officer for branded markets (India and emerging markets), said the launch would add to the companys diabetes portfolio and expand treatment options